The analysis on the decision tree confirmed that treatment success among pregnant women with diabetes and mild hyperglycemia was associated with cost reduction, regardless of management method (inpatient or outpatient) and treatment type (diet or diet + insulin). The gene discussed is INS; the disease is Hyperglycemia.